Transplant Pulmonology
Zambon S.p.A. is active in lung transplantation-related care, with research focused on bronchiolitis obliterans syndrome in recipients of single or double lung transplants.
- Post-transplant bronchiolitis obliterans syndrome
- Single lung transplantation
- Double lung transplantation
The sponsor’s clinical interest is centered on respiratory complications that affect long-term graft function after transplantation.
Immunosuppression and Graft Health
The research landscape includes therapies aimed at maintaining allograft function and addressing chronic rejection in lung transplant recipients.
- Allograft dysfunction
- Chronic lung rejection
- Long-term transplant maintenance
Clinical activity in this area reflects interest in conditions that threaten respiratory stability after transplantation.
Calcineurin Inhibitor-Based Therapy
Research activity includes cyclosporine-based treatment strategies, with attention to inhaled or liposomal delivery approaches for transplant-related respiratory disease.
- Liposomal cyclosporine A
- Inhaled immunomodulatory therapy
- Supportive standard of care treatment
This therapeutic domain is aligned with managing inflammatory and immune-mediated injury in the transplanted lung.
Long-Term Safety and Efficacy Evaluation
The sponsor’s trial portfolio includes ongoing assessment of treatment durability, safety, and clinical benefit in patients continuing care after earlier transplant studies.
- Extended follow-up in transplant recipients
- Safety monitoring
- Clinical benefit assessment
These interests are concentrated on sustained management of respiratory complications in a specialized transplant population.
